1.    Fick-Brosnahan GM, Ecder T, Schrier RW: Chapter 18: Polycystic Kidney Disease. Diseases of the Kidney and Urinary Tract. Seventh Edition. Edited by Robert W. Schrier. Lippincott Williams and Wilkins, pp: 547-588, 2001.
2.    Ecder T, Hockensmith ML, Korular D, Schrier RW: Hypertension, Diabetes and the Heart. Medical Management of Diabetes and Heart Disease. Edited by Burton E. Sobel, David J. Schneider. Markel Dekker, Inc. Pp: 65-84, 2002.  
3.    Ecder T, Fick-Brosnahan GM, Schrier RW: Chapter 18: Polycystic Kidney Disease. Diseases of the Kidney and Urinary Tract. Eigth Edition. Edited by Robert W. Schrier. Lippincott Williams and Wilkins 2007.
4.    Ecder T: Epidemiology/Prevalence of Dyslipidemia in the General Population and in Patients with Chronic Kidney Disease. Dyslipidemias in Kidney Disease. Editors: Covic, Kanbay, Lerma. Springer 2014.
5.    Ecder T, Arıcı M, Ateş K, Söylemezoğlu O, Süleymanlar G, Türkmen A: Nephrology in Turkey. Nephrology Worldwide. Editors: Moura-Neto, Divino-Filho, Ronco. Springer 2021.

2. Publications in journals within the scope of “Science Citation Index (SCI)”

a. Original research, articles and reviews

1.    Sever MŞ, Ecder T, Aydın AE, Türkmen A, Kılıçaslan I, Uysal V, Eraksoy H, Çalangu S, Çarin M, Eldegez U: Living unrelated (paid) kidney transplantation in Third-World countries: High risk of complications besides the ethical problem.  Nephrology Dialysis Transplantation 9:350-354, 1994.
2.    Türkmen A, Sever MŞ, Ecder T, Yıldız A, Aydın AE, Erkoç R, Eraksoy H, Eldegez U, Ark E: Posttransplant malaria. Transplantation 62:1521-1523, 1996.                    
3.    Türk S, Bozfakıoğlu S, Ecder ST, Kahraman T, Gürel N, Erkoç R, Aysuna N, Türkmen A, Bekiroğlu N, Ark E: Effects of zinc supplementation on the immune system and on antibody response to multivalent influenza vaccine in hemodialysis patients. The International Journal of Artificial Organs 21: 274-278, 1998.        
4.    Türkmen A, Yıldız A, Erkoç R, Ecder T, Görçin B, Türk S, Aydın AE, Eldegez U, Ark E, Sever MŞ: Transplantation in renal amyloidosis. Clinical Transplantation 12: 375-378, 1998.            
5.    Ecder ST, Sever MŞ, Yıldız A, Türkmen A, Kayacan SM, Kılıçaslan I, Koçak T, Eldegez U: Kaposi’s sarcoma after renal transplantation in Turkey. Clinical Transplantation 12: 472-475, 1998.     
6.    Yıldız A, Sever MŞ, Türkmen A, Ecder T, Beşışık F, Tabak L, Kılıçarslan I, Ark E: Tuberculosis after renal transplantation: experience of one Turkish centre. Nephrology Dialysis Transplantation 13: 1872-1875, 1998.
7.    Sever MŞ, Türkmen A, Yıldız A, Ecder T, Orhan Y: Fever in dialysis patients with recently rejected renal allografts. The International Journal of Artificial Organs 21: 403-407, 1998.            
8.    Yıldız A, Sever MŞ, Demirel Ş, Akkaya V, Türk S, Türkmen A, Ecder T, Ark E: Improvement of uremic autonomic dysfunction after renal transplantation: A heart rate variability study. Nephron 80: 57-60, 1998.    
9.    Yıldız A, Erkoç R, Sever MŞ, Türkmen A, Ecder ST, Türk S, Kılıçarslan I, Ark E: The prognostic importance of severity and type of post-transplant proteinuria. Clinical Transplantation 13: 241-244, 1999.        
10.    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation 14: 1113-1116, 1999.    
11.    Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW: Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. American Journal of Kidney Diseases 35: 427-432, 2000.            
12.    Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, Schrier RW: Progress in blood pressure control in autosomal dominant polycystic kidney disease. American Journal of Kidney Diseases 36: 266-271, 2000.    
13.    Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW: Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. American Journal of Nephrology 21: 98-103, 2001.        
14.    Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. The Journal of Clinical Investigation 107: 1145-1152, 2001.    
15.    Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW: Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney International 59: 2243-2249, 2001. 
16.    Sever MŞ, Kazancıoğlu R, Yıldız A, Türkmen A, Ecder T, Kayacan SM, Çelik V, Şahin S, Aydın AE, Eldegez U, Ark E: Outcome of living unrelated (commercial) renal transplantation. Kidney International 60: 1477-1483, 2001.          
17.    Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. Journal of the American Society of Nephrology 12: 194-200, 2001.    
18.    Ecder T, Korular D, Gurevich AK, Weinberger HD, Schrier RW: Therapy of heart failure. Current Opinion in Investigational Drugs 2(1):81-86, 2001.                            
19.    Schrier RW, Ecder T: Unifying hypothesis of body fluid volume regulation: Implications for cardiac failure and cirrhosis. Mount Sinai Journal of Medicine 68:350-361, 2001.                 
20.    Sever MS, Turkmen A, Sahin S, Yıldız A, Ecder T, Kayacan MS, Nane I, Aydin AE, Eldegez U: Renal transplantation in amyloidosis secondary to Familial Mediterranean Fever. Transplantation Proceedings 33: 3392-3393, 2001.        
21.    Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, Edelstein CL: Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 61: 1220-1230, 2002.
22.    Bayraktar G, Kazancıoglu R, Bozfakıoglu S, Ecder T, Yıldız A, Ark E: Stimulated salivary flow rate in chronic hemodialysis patients. Nephron 91(2): 210-214, 2002.
23.    Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J Am Soc Nephrol 13: 1733-1739, 2002.    
24.    Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW: Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62: 566-573, 2002. 
25.    Ecder T, McFann KK, Raynolds MV, Schrier RW: No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. American Journal of Nephrology 23: 466-470, 2003.
26.    Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW: Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. Journal of Cardiac Failure 10: 126-131, 2004.
27.    Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T: Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. American Journal of Kidney Diseases 43: 854-860, 2004.  
28.    Ecder T, Schrier RW: Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Expert Rev Cardiovasc Ther 2(3), 369-374, 2004.        
29.    Oflaz H, Alisir S, Buyukaydın B, Kocaman O, Turgut F, Namli S, Pamukcu B, Oncul A, Ecder T: Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney International 68: 2244-2249, 2005.  
30.    Caliskan Y, Besisik SK, Sargin D, Ecder T: Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant 38 (2): 141-147, 2006.  
31.    Namli S, Oflaz H, Turgut F, Alisir S, Tufan F, Ucar A, Mercanoglu F, Ecder T: Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease. Renal Failure 29 (1): 55-59, 2007.
32.    Turgut F, Oflaz H, Namli S, Alisir S, Tufan F, Temiz S, Umman S, Ecder T: Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Renal Failure 29: 979-984, 2007.    
33.    Turkmen K, Oflaz H, Uslu B, Cimen AO, Elitok A, Kasikcioglu E, Alisir S, Tufan F, Namli S, Uysal M, Ecder T: Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: From impaired tubules to impaired carotid and coronary arteries. Clinical Journal of American Society of Nephrology 3: 986-991, 2008.
34.    Parving H-H, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, for the AVOID Study Investigators. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358: 2433-2446, 2008. 
35.    Atamer A, Alisir Ecder S, Akkus Z, Kocyigit Y, Atamer Y, Ilhan N, Ecder T:  Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. The Journal of International Medical Research 36: 522-528, 2008.   
36.    Atamer A, Kocyigit Y, Ecder SA, Selek S, Ilhan N, Ecder T, Atamer Y: Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol 21(6): 924-930, 2008.  
37.    Ecder T, Schrier RW: Cardiovascular abnormalities in autosomal dominant polycystic kidney disease. Nature Reviews Nephrology 5: 221-228, 2009.
38.    Ecder T: Influence of protein-restricted diets on proteinuria and endothelial dysfunction. Journal of Renal Nutrition 19 (5 Suppl): S13-S14, 2009.
39.    Aparicio M, Cano NJ, Cupisti A, Ecder T, Fouque D, Garneata L, Liou HH, Lin S, Schober-Halstenberg HJ, Teplan V, Zakar G. Keto-acid therapy in predialysis chronic kidney disease patients: consensus statements. Journal of Renal Nutrition 19 (5 Suppl): S33-S35, 2009.
40.    Locatelli F, Palmer BF, Kashihara N, Ecder T: Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan. Curr Med Res Opin Oct 16, 2009.  
41.    Ecder T: Renin inhibition and kidney. Arch Turk Soc Cardiol 37 Suppl 7: 28-31, 2009.
42.    Alisir S, Turkmen K, Alpay N, Elitok A, Oflaz H, Uslu B, Cimen A, Kasikcioglu E, Tufan F, Ecder T: Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal dominant polycystic kidney disease. Southern Medical Journal 103(5): 409-413, 2010.
43.    Kazancioglu R, Ecder T, Altintepe L, Altiparmak MR, Tuglular S, Uyanik A, Cavdar C, Alisir Ecder S, Tokgoz B, Duman N, Duzova A, Cetinkaya R on the behalf of the Turkish Society of Nephrology Polycystic Kidney Disease Working Group. Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: A multicenter experience. Nephron Clin Pract 117(3):c270-c275, 2010.
44.    Tufan F, Uslu B, Cekrezi B, Uysal M, Alpay N, Turkmen K, Disci R, Ozbey NC, Ecder T: Assessment of adrenal functions in patients with autosomal dominant polycystic kidney disease. Experimental and Clinical Endocrinology and Diabetes 118: 741-746, 2010. 
45.    Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, Ecder T, Yilmaz ME, Çamsari T, Başçi A, Serdengeçti K: A population-based survey of Chronic REnal Disease In Turkey – the CREDIT study. Nephrol Dial Transplant, 26: 1862-1871, 2011.
46.    Turkmen K, Tufan F, Alpay N, Kasikcioglu E, Oflaz H, Alisir S, Ecder T: Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease. Internal Medicine Journal 42: 146-153, 2012.
47.    Kanbay M, Turkmen K, Ecder T, Covic A: Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol 44: 173-182, 2012.
48.    Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, Fouque D, Garneata L, Lin S, Mitch WE, Teplan V, Zakar G, Yu X. Protein-restricted diets plus keto/amino acids – a valid therapeutic approach for chronic kidney disease patients. Journal of Renal Nutrition 22 (2 Suppl):S1-S21, 2012.
49.    Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, Fouque D, Garneata L, Lin S, Mitch WE, Teplan V, Zakar G, Yu X. Keto Acid therapy in predialysis chronic kidney disease patients: final consensus. Journal of Renal Nutrition 22 (2 Suppl):S22-4, 2012.
50.    Caliskan Y, Ozkok A, Akagun T, Alpay N, Guz G, Polat N, Tufan F, Ecder T, Bozfakioglu S: Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients. Kidney and Blood Pressure Research, 35 (5): 340-348, 2012.
51.    Altun B, Suleymanlar G, Utas C, Arinsoy T, Ates K, Ecder T, Camsari T, Serdengecti K: Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: Results from the CREDIT study. Kidney and Blood Pressure Research, 36 (1): 36-46, 2012. 
52.    Ozkok A, Akpinar TS, Tufan F, Kanitez NA, Uysal M, Guzel M, Caliskan M, Alisir S, Yazici H, Ecder T: Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol, 17(3): 345-351, 2013.
53.    Türkmen K, Tufan F, Selçuk E, Akpınar T, Oflaz H, Ecder T: Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Indian J Nephrol 23(1): 34-40, 2013.
54.    Ecder T: Cardiovascular complications in autosomal dominant polycystic kidney disease. Current Hypertension Reviews, 9 (1): 2 – 11, 2013.
55.    Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, Fouque D, Garneata L, Lin S, Mitch W, Teplan V, Yu X, Zakar G: Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients? Seminars in Dialysis 26 (6): 714 – 719, 2013.
56.    Ecder T: Early diagnosis saves lives: focus on patients with chronic kidney disease. Kidney Int Suppl 3 (4): 335-336, 2013.
57.    Ozkok A, Akpinar TS, Tufan F, Kaya O, Bozbey HU, Atas R, Toz B, Atay K, Yilmaz E, Besiroglu M, Nas K, Hadrovic N, Illyés M, Ecder T: Cystatin C is better than albuminuria as a predictor of pulse wave velocity in hypertensive patients. Clin Exp Hypertens 36 (4): 222 – 226, 2014.
58.    Turkmen K, Tufan F, Engin S, Akpinar T, Oflaz H, Ecder T: Author’s reply (Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Indian J Nephrol 23(1): 34-40, 2013). Indian J Nephrol 24 (1): 66, 2014.
59.    Spithoven EM, Kramer A, Meijer E et al., on behalf of the ERA-EDTA Registry, the EuroCYST Consortium and the WGIKD: Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival – an analysis of data from the ERA – EDTA Registry. Nephrol Dial Transplant 29: iv15 – iv25, 2014.
60.    Petzold K, Gansevoort RT, Ong ACM, Devuyst O, Rotar L, Eckardt K-U, Köttgen A, Pirson Y, Remuzzi G, Sanford R, Tesar V, Ecder T, Chaveau D, Torra R, Budde K, Le Meur Y, Wüthrich RP, Serra AL: Building a network of ADPKD reference centres across Europe: the EuroCYST initiative. Nephrol Dial Transplant 29: iv26 – iv32, 2014.
61.    Yelken B, Gorgulu N, Gursu M, Yazici H, Caliskan Y, Telci A, Ozturk S, Kazancioglu R, Ecder T, Bozfakioglu S: Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients. Adv Perit Dial 30: 5 – 10, 2014.
62.    Sinangil A, Celik V, Barlas S, Akin EB, Ecder T: Should transplant ureter be stented routinely or not? Eur Rev Med Pharmacol Sci. 18(23):3551-6, 2014.
63.    Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD; EuroCYST Consortium; WGIKD. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int. 86(6):1244-1252, 2014. 
64.    Ecder T: Renal and metabolic effects of valsartan. Anadolu Kardiyol Derg. Suppl 2:S14-9, 2014.
65.    Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 88(1):17-27, 2015.
66.    Palmer SC, Ruospo M, Campbell KL, Larsen VG, Saglimbene V, Natale P, Gargano L, Craig JC, Johnson DW, Tonelli M, Knight J, Bednarek-Skublewska A, Celia E, del Castillo D, Dulawa J, Ecder T, Fabricius E, Frazao JM, Gelfman R, Hoischen SH, Schön S, Stroumza P, Timofte D, Török M, Hegbrant J, Wollheim C, Frantzen L, Strippoli GFM: Nutrition and dietary intake and their association with mortality and hospitalization in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study. BMJ Open March 23, 2015.
67.    Emre T, Kiliçkesmez Ö, Büker A, İnal BB, Doğan H, Ecder T: Renal function and diffusion-weighted imaging: a new method to diagnose kidney failure before losing half function. Radiol Med 121: 163-172, 2016.
68.    Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T: New-onset diabetes after kidney transplantation and pretransplant hypomagnesemia. Progress in Transplantation 26 (1): 55 – 61, 2016.   
69.    Ecder T: Statins in the treatment of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 31 (8): 1194-1196, 2016.
70.    Ecder T: Is glomerular filtration rate a marker of severity of coronary heart disease? Turk Kardiyol Dern Arş 44: 98-99, 2016.
71.    Arinsoy T, Deger SM, Ates K, Altun B, Ecder T, Camsari T, Serdengecti K, Suleymanlar G: Prevalence of chronic kidney disease in Turkish adults with obesity and metabolic syndrome: A post hoc analysis from Chronic Renal Disease in Turkey study. J Ren Nutr. 26 (6): 373-379, 2016. 
72.    Aşık M, Tufan F, Akpınar TS, Akalın N, Ceyhan E, Tunç N, Hasıloğlu ZI, Altıparmak MR, Ecder T, Albayram S: Frequency of Nerve Root Sleeve Cysts in Autosomal Dominant Polycystic Kidney Disease. Balkan Med J. 2016 Nov;33(6):652-656. 
73.    Kocyigit I, Sener EF, Taheri S, Eroglu E, Ozturk F, Unal A, Zararsiz G, Uzun I, Imamoglu H, Sipahioglu MH, Tokgoz B, Oymak O, Ecder T: Toll-like receptors in the progression of autosomal dominant polycystic kidney disease. Ther Apher Dial, 2016 Dec: 20 (6): 615-622.
74.    Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bedranek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schön S, Wollheim C, Hegbrant J, Strippoli GF: Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study. Nephrol Dial Transplant 2017; 32(2): 377-384.
75.    Ecder T, Utas C, Ates K, Bieber B, Robinson BM, Pisoni RL, Süleymanlar G. The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey. Hemodial Int. 2017; 21(3): 430-439.
76.    Sinangil A, Celik V, Barlas S, Koc Y, Basturk T, Sakaci T, Akin EB, Ecder T: The incidence of new onset diabetes after transplantation and related factors. Nefrologia, 2017: 37(2): 181-188.
77.    Kocyigit I, Taheri S, Sener EF, Eroglu E, Ozturk F, Unal A, Korkmaz K, Zararsız G, Sipahioglu MH, Ozkul Y, Tokgoz B, Oymak O, Ecder T, Axelsson J: Serum micro-RNA profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function. BMC Nephrology 2017: 18: 179.
78.    Rayner HC, Larkina M, Wand M, Graham-Brown M, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber BA, Tentori F, Robinson BM, Pisoni RL: International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol 12: 2000-2007, 2017. 
79.    Kaya O, Tufan F, Basar R, Akpinar TS, Atay K, Alpay N, Nas K, Illyes M, Ecder ST: The effect of Helicobacter pylori eradication on arterial stiffness and qt dispersion. Biomedical Research 2017; 28 (2): 503-507. 
80.    Harris T, Sandford R, de Coninck B, Devuyst O, Drenth JPH, Ecder T, Kent A, Gansevoort RT, Górriz JL, Ong ACM, Pirson Y, Torres VE, Budde K, Clément D, Derchi LE, Eleftheroudi M, Levtchenko E, Peters D, Van Poppel H, Vanholder R. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants. Nephrol Dial Transplant. 33: 563-573, 2018. 
81.    Saglimbene VM, Wong G, Craig JC, Ruospo M, Palmer SC, Campbell K, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Strippoli GFM. The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study. J Am Soc Nephrol. 2018; 29(6): 1741-1751.
82.    Saglimbene VM, Wong G, Ruospo M, Palmer SC, Campbell K, Larsen VG, Natale P, Teixeira-Pinto A, Carrero J-J, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Dulawa J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM: Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study. Clinical Nutrition 38: 429-439, 2019
83.    Yalın SF, Eren N, Sinangil A, Yılmaz VT, Tatar E, Ucar AR, Sevinc M, Can O, Gurkan A, Aril N, Alisir Ecder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, Cevher SK, Turkmen K, Guven B, Taymez DG, Senates BE, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, Bicik Bahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altıparmak MR, Turkmen A, Seyahi N: Fabry disease prevalence in renal replacement therapy in Turkey. Nephron Clinical Practice, February 8, 2019.
84.    Ecder T: Which dialysis modality is better for the heart? Turk Kardiyol Dern Ars 47 (2): 85-87, 2019.
85.    Saglimbene VM, Wong G, Ruospo M, Palmer SC, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Campbell KL, Carrero J-J, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Torok M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM. Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis.  Clin J Am Soc Nephrol 14: 250-260, 2019.
86.    Yalın SF, Eren N, Sisngil A, Yilmaz VT, Tatar E, Ucar AR, Sevinc M, Can Ö, Gurkan A, Arik N, Alisir Ecder S, Uyar M, Yasar M, Gulcicek S, Mese M, Dheir H, Cakir U, Cevher SK, Turkmen K, Guven B, Guven Taymez D, Erkalma Senates B, Ecder T, Kocak H, Uslu A, Demir E, Basturk T, Ogutmen MB, Kinalp C, Dursun B, Bicik Bahcebasi Z, Sipahi S, Dede F, Oruc M, Caliskan Y, Genc A, Yelken B, Altıparmak MR, Turkmen A, Seyahi N: Fabry disease prevalence in renal replacement therapy in Turkey. Nephron 142 (1): 26-33, 2019.
87.    Kocyigit I, Ozturk F, Eroglu E, Karaca Z, Kaynar AS, Cetin M, Tokgoz B, Sipahioglu MH, Bayramov R, Sen A, Oymak O, Ecder T, Axelsson J: Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease. Clinical and Experimental Nephrology 2019.
88.    Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, Al Shakarchi J, Berger P, Bolignano D, Cassidy D, Chan TY, Dhondt A, Drechsler C, Ecder T, Finocchiaro P, Haller M, Hanko J, Heye S, Ibeas J, Jemcov T, Kershaw S, Khawaja A, Labriola L, Lomonte C, Malovrh M, Marti I Monros A, Matthew S, McGrogan D, Meyer T, Mikros S, Nistor I, Planken N, Roca-Tey R, Ross R, Troxler M, van der Veer S, Vanholder R, Vermassen F, Welander G, Wilmink T, Koobasi M, Fox J, Van Biesen W, Nagler E. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transplant. 2019 Jun 1;34(Supplement_2):ii1-ii42. doi: 10.1093/ndt/gfz072.
89.    Barlas IS, Aydogdu I, Sinangil A, Ucar ZA, Koc Y, Ecder T, Akin EB: Hand-assisted nephrectomy predisposes incisional herniation in obese living donors. Tranplantation Proceedings 51, 2210-2214, 2019.
90.    Sinangil A, Ucar ZA, Koc Y, Barlas S, Abouzahir S, Ecder ST, Akin EB: Outcome of desensitization therapy in immunologically high-risk kidney transplantation: Sinlge-center experience. Tranplantation Proceedings 51, 2268-2273, 2019.
91.    Ucar ZA, Sinangil A, Koc Y, Barlas S, Abouzahir S, Ecder T, Akin EB: Clinical prognosis of renal retransplant patients: A single-center experience. Tranplantation Proceedings 51, 2274-2278, 2019.
92.    Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, Al Shakarchi J, Berger P, Bolignano D, Cassidy D, Chan TY, Dhondt A, Drechsler C, Ecder T, Finocchiaro P, Haller M, Hanko J, Heye S, Ibeas J, Jemcov T, Kershaw S, Khawaja A, Labriola L, Lomonte C, Malovrh M, Marti I Monros A, Matthew S, McGrogan D, Meyer T, Mikros S, Nistor I, Planken N, Roca-Tey R, Ross R, Troxler M, van der Veer S, Vanholder R, Vermassen F, Welander G, Wilmink T, Koobasi M, Fox J, Van Biesen W, Nagler E. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transplant. 2020 Dec 4;35(12):2203. doi: 10.1093/ndt/gfaa106.
93.    Saglimbene VM, Wong G, Teixeira-Pinto A, Ruospo M, Garcia-Larsen V, Palmer SC, Natale P, Campbell K, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM; DIET-HD Investigators and Dieticians. Dietary Patterns and Mortality in a Multinational Cohort of Adults Receiving Hemodialysis. Am J Kidney Dis. 2020 Mar;75(3):361-372. 
94.    Ryu H, Park HC, Oh YK, Sangadi I, Wong A, Mei C, Ecder T, Wang AY, Kao TW, Huang JW, Rangan GK, Ahn C. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study. BMJ Open. 2020 Feb 6;10(2):e034103. doi: 10.1136/bmjopen-2019-034103. 
95.    Ozen N, Sayilan AA, Mut D, Sayilan S, Avcioglu Z, Kulakac N, Ecder T, Akyolcu N: The effect of chewing gum on dry mouth, interdialytic weight gain, and intradialytic symptoms: A prospective, randomized controlled trial. Hemodial Int. 2021 25: 94-103.
96.    Arıcı M, Ecder T, Erdinler İ, Ok E, Arıcan Öztürk Ö, Türk UÖ, Alioğlu E: New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) – Where do we stand?: An expert consensus view using the Delphi method. Turk Kardiyol Dern Ars. 2021 Jul;49(5):345-352. doi: 10.5543/tkda.2021.40652. 
97.    Erdem E, Karataş A, Ecder T: The relationship between serum ferritin levels and 5-year all-cause mortality in hemodialysis patients. Blood Purif. 2021 Apr 7:1-7. doi: 10.1159/000515639. Online ahead of print. 
98.    Ozen N, Aydin Sayilan A, Sayilan S, Mut D, Akin EB, Ecder ST: Relationship between arteriovenous fistula cannulation practices and dialysis adequacy: A prospective, multicenter study. J Ren Care. 2021 Jan 25. doi: 10.1111/jorc.12365. Online ahead of print.
99.    Eren Sadioglu R, Ustuner E, Ergun I, Ecder ST, Nergizoglu G, Keven K: Warfarin is associated with the risk of vascular calcification in abdominal aorta in hemodialysis patients: A multicenter case-sontrol study. Turk J Med Sci. 2021 Jul 22. doi: 10.3906/sag-2104-221. Online ahead of print.
100.    Akpinar TS, Kucukdagli P, Ozer PK, Karaayvaz EB, Ince B, Bakkaloglu OK, Sarihan I, Medetalibeyoglu A, Antinkaynak M, Uzun DD, Bozbora E, Kose M, Ecder T, Yazici H: Subclinic arterial and left ventricular systolic impairment in autosomal dominant polycystic kidney disease with preserved renal functions. Int J Cardiovasc Imaging. 2021